# Correction: Screening potential anti-osteoarthritis compounds using molecular docking based on MAPK and NFκB pathways and validating their anti-osteoarthritis effect

**Authors:** Tian-Wang Zhu, Yu Zheng, Rui-Xin Li

PMC · DOI: 10.1371/journal.pone.0324192 · PLOS One · 2025-05-14

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** osteoarthritis (MESH:D010003), cytotoxicity (MESH:D064420)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12077689/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12077689/full.md

---
Source: https://tomesphere.com/paper/PMC12077689